Thank you.
I'll continue on that topic with Ms. Silas.
Am I right to understand that as a result of the preliminary introduction of these two types of products—diabetes products as well as contraceptives—it will allow more room in the broader insurance programs and benefits, so it can help to actually broaden the scope of other services, as you were saying? Did I understand you correctly? Can you expand on that?